Furnishings, Fixtures & Appliances
Compare Stocks
5 / 10Stock Comparison
IRBT vs NVCR vs HELE vs SWK vs TTI
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
Household & Personal Products
Manufacturing - Tools & Accessories
Oil & Gas Equipment & Services
IRBT vs NVCR vs HELE vs SWK vs TTI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Furnishings, Fixtures & Appliances | Medical - Instruments & Supplies | Household & Personal Products | Manufacturing - Tools & Accessories | Oil & Gas Equipment & Services |
| Market Cap | $2M | $1.92B | $595M | $12.47B | $1.32B |
| Revenue (TTM) | $547M | $674M | $1.79B | $15.23B | $630M |
| Net Income (TTM) | $-209M | $-173M | $-899M | $371M | $7M |
| Gross Margin | 22.0% | 75.2% | 45.7% | 30.0% | 24.6% |
| Operating Margin | -29.5% | -27.2% | 6.0% | 7.8% | 8.4% |
| Forward P/E | — | — | 7.5x | 17.6x | 41.4x |
| Total Debt | $227M | $290M | $78M | $5.86B | $263M |
| Cash & Equiv. | $134M | $103M | $19M | $280M | $45M |
IRBT vs NVCR vs HELE vs SWK vs TTI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Feb 26 | Return |
|---|---|---|---|
| iRobot Corporation (IRBT) | 100 | 0.1 | -99.9% |
| NovoCure Limited (NVCR) | 100 | 18.4 | -81.6% |
| Helen of Troy Limit… (HELE) | 100 | 9.1 | -90.9% |
| Stanley Black & Dec… (SWK) | 100 | 62.7 | -37.3% |
| TETRA Technologies,… (TTI) | 100 | 3454.5 | +3354.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IRBT vs NVCR vs HELE vs SWK vs TTI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, IRBT doesn't own a clear edge in any measured category.
NVCR ranks third and is worth considering specifically for growth exposure.
- Rev growth 8.3%, EPS growth 21.8%, 3Y rev CAGR 6.8%
- 8.3% revenue growth vs IRBT's -23.4%
HELE is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.65, Low D/E 9.8%, current ratio 1.71x
- Lower P/E (7.5x vs 41.4x)
SWK carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 16 yrs, beta 1.83, yield 4.1%
- 2.4% margin vs HELE's -50.3%
- 4.1% yield; 16-year raise streak; the other 4 pay no meaningful dividend
- 1.7% ROA vs IRBT's -43.3%, ROIC 5.8% vs -38.6%
TTI is the #2 pick in this set and the best alternative if long-term compounding and defensive is your priority.
- 96.4% 10Y total return vs SWK's -1.5%
- Beta 1.46, current ratio 2.02x
- Beta 1.46 vs IRBT's 5.21, lower leverage
- +246.3% vs IRBT's -97.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.3% revenue growth vs IRBT's -23.4% | |
| Value | Lower P/E (7.5x vs 41.4x) | |
| Quality / Margins | 2.4% margin vs HELE's -50.3% | |
| Stability / Safety | Beta 1.46 vs IRBT's 5.21, lower leverage | |
| Dividends | 4.1% yield; 16-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +246.3% vs IRBT's -97.7% | |
| Efficiency (ROA) | 1.7% ROA vs IRBT's -43.3%, ROIC 5.8% vs -38.6% |
IRBT vs NVCR vs HELE vs SWK vs TTI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IRBT vs NVCR vs HELE vs SWK vs TTI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TTI leads in 1 of 6 categories
SWK leads 1 • IRBT leads 0 • NVCR leads 0 • HELE leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NVCR and TTI each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SWK is the larger business by revenue, generating $15.2B annually — 27.8x IRBT's $547M. SWK is the more profitable business, keeping 2.4% of every revenue dollar as net income compared to HELE's -50.3%. On growth, NVCR holds the edge at +12.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $547M | $674M | $1.8B | $15.2B | $630M |
| EBITDAEarnings before interest/tax | -$151M | -$165M | $107M | $1.7B | $90M |
| Net IncomeAfter-tax profit | -$209M | -$173M | -$899M | $371M | $7M |
| Free Cash FlowCash after capex | -$107M | -$48M | $171M | $726M | $3M |
| Gross MarginGross profit ÷ Revenue | +22.0% | +75.2% | +45.7% | +30.0% | +24.6% |
| Operating MarginEBIT ÷ Revenue | -29.5% | -27.2% | +6.0% | +7.8% | +8.4% |
| Net MarginNet income ÷ Revenue | -38.2% | -25.7% | -50.3% | +2.4% | +1.2% |
| FCF MarginFCF ÷ Revenue | -19.6% | -7.1% | +9.6% | +4.8% | +0.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -24.6% | +12.3% | -3.3% | +2.7% | -0.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -195.2% | -100.0% | -2.1% | -35.0% | +100.0% |
Valuation Metrics
Evenly matched — IRBT and HELE each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 30.3x trailing earnings, SWK trades at a 93% valuation discount to TTI's 439.9x P/E. On an enterprise value basis, SWK's 11.7x EV/EBITDA is more attractive than TTI's 15.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2M | $1.9B | $595M | $12.5B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $95M | $2.1B | $654M | $18.0B | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -13.80x | -0.66x | 30.26x | 439.86x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 7.53x | 17.64x | 41.38x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 11.71x | 15.93x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 2.92x | 0.33x | 0.82x | 2.09x |
| Price / BookPrice ÷ Book value/share | 0.03x | 5.51x | 0.74x | 1.35x | 4.67x |
| Price / FCFMarket cap ÷ FCF | — | — | 3.48x | 18.12x | 67.62x |
Profitability & Efficiency
Evenly matched — HELE and SWK and TTI each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
SWK delivers a 4.1% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-113 for IRBT. HELE carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRBT's 3.71x. On the Piotroski fundamental quality scale (0–9), SWK scores 6/9 vs IRBT's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -112.9% | -50.8% | -94.5% | +4.1% | +2.5% |
| ROA (TTM)Return on assets | -43.3% | -16.5% | -37.8% | +1.7% | +1.1% |
| ROICReturn on invested capital | -38.6% | -16.4% | +4.6% | +5.8% | +9.5% |
| ROCEReturn on capital employed | -27.7% | -28.9% | +5.0% | +7.0% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 5 | 6 | 4 |
| Debt / EquityFinancial leverage | 3.71x | 0.85x | 0.10x | 0.65x | 0.93x |
| Net DebtTotal debt minus cash | $93M | $187M | $59M | $5.6B | $218M |
| Cash & Equiv.Liquid assets | $134M | $103M | $19M | $280M | $45M |
| Total DebtShort + long-term debt | $227M | $290M | $78M | $5.9B | $263M |
| Interest CoverageEBIT ÷ Interest expense | -3.36x | -96.80x | -5.02x | 2.07x | 2.96x |
Total Returns (Dividends Reinvested)
TTI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TTI five years ago would be worth $28,304 today (with dividends reinvested), compared to $6 for IRBT. Over the past 12 months, TTI leads with a +246.3% total return vs IRBT's -97.7%. The 3-year compound annual growth rate (CAGR) favors TTI at 48.9% vs IRBT's -88.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -55.0% | +28.3% | +25.2% | +5.9% | -0.3% |
| 1-Year ReturnPast 12 months | -97.7% | +1.1% | +5.4% | +41.7% | +246.3% |
| 3-Year ReturnCumulative with dividends | -99.9% | -75.7% | -73.2% | +6.9% | +229.9% |
| 5-Year ReturnCumulative with dividends | -99.9% | -91.3% | -88.6% | -56.2% | +183.0% |
| 10-Year ReturnCumulative with dividends | -99.9% | +30.3% | -74.4% | -1.5% | +96.4% |
| CAGR (3Y)Annualised 3-year return | -88.8% | -37.6% | -35.5% | +2.2% | +48.9% |
Risk & Volatility
Evenly matched — SWK and TTI each lead in 1 of 2 comparable metrics.
Risk & Volatility
TTI is the less volatile stock with a 1.46 beta — it tends to amplify market swings less than IRBT's 5.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SWK currently trades 85.9% from its 52-week high vs IRBT's 0.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 5.21x | 2.20x | 1.65x | 1.83x | 1.46x |
| 52-Week HighHighest price in past year | $6.10 | $20.06 | $33.76 | $93.37 | $12.54 |
| 52-Week LowLowest price in past year | $0.04 | $9.82 | $13.85 | $58.23 | $2.63 |
| % of 52W HighCurrent price vs 52-week peak | +0.9% | +83.9% | +76.5% | +85.9% | +77.9% |
| RSI (14)Momentum oscillator 0–100 | 33.9 | 69.8 | 78.4 | 61.0 | 63.6 |
| Avg Volume (50D)Average daily shares traded | 0 | 1.5M | 627K | 2.0M | 1.8M |
Analyst Outlook
SWK leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NVCR as "Buy", HELE as "Hold", SWK as "Hold", TTI as "Buy". Consensus price targets imply 99.0% upside for NVCR (target: $34) vs -14.8% for HELE (target: $22). SWK is the only dividend payer here at 4.10% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $33.50 | $22.00 | $89.17 | $12.25 |
| # AnalystsCovering analysts | — | 15 | 11 | 37 | 31 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +4.1% | — |
| Dividend StreakConsecutive years of raises | — | — | — | 16 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $3.29 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.3% | +0.1% | 0.0% |
TTI leads in 1 of 6 categories (Total Returns). SWK leads in 1 (Analyst Outlook). 4 tied.
IRBT vs NVCR vs HELE vs SWK vs TTI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IRBT or NVCR or HELE or SWK or TTI a better buy right now?
For growth investors, NovoCure Limited (NVCR) is the stronger pick with 8.
3% revenue growth year-over-year, versus -23. 4% for iRobot Corporation (IRBT). Stanley Black & Decker, Inc. (SWK) offers the better valuation at 30. 3x trailing P/E (17. 6x forward), making it the more compelling value choice. Analysts rate NovoCure Limited (NVCR) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IRBT or NVCR or HELE or SWK or TTI?
On trailing P/E, Stanley Black & Decker, Inc.
(SWK) is the cheapest at 30. 3x versus TETRA Technologies, Inc. at 439. 9x. On forward P/E, Helen of Troy Limited is actually cheaper at 7. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IRBT or NVCR or HELE or SWK or TTI?
Over the past 5 years, TETRA Technologies, Inc.
(TTI) delivered a total return of +183. 0%, compared to -99. 9% for iRobot Corporation (IRBT). Over 10 years, the gap is even starker: TTI returned +96. 4% versus IRBT's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IRBT or NVCR or HELE or SWK or TTI?
By beta (market sensitivity over 5 years), TETRA Technologies, Inc.
(TTI) is the lower-risk stock at 1. 46β versus iRobot Corporation's 5. 21β — meaning IRBT is approximately 258% more volatile than TTI relative to the S&P 500. On balance sheet safety, Helen of Troy Limited (HELE) carries a lower debt/equity ratio of 10% versus 4% for iRobot Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — IRBT or NVCR or HELE or SWK or TTI?
By revenue growth (latest reported year), NovoCure Limited (NVCR) is pulling ahead at 8.
3% versus -23. 4% for iRobot Corporation (IRBT). On earnings-per-share growth, the picture is similar: iRobot Corporation grew EPS 55. 3% year-over-year, compared to -827. 7% for Helen of Troy Limited. Over a 3-year CAGR, NVCR leads at 6. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IRBT or NVCR or HELE or SWK or TTI?
Stanley Black & Decker, Inc.
(SWK) is the more profitable company, earning 2. 7% net margin versus -50. 3% for Helen of Troy Limited — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TTI leads at 9. 4% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IRBT or NVCR or HELE or SWK or TTI more undervalued right now?
On forward earnings alone, Helen of Troy Limited (HELE) trades at 7.
5x forward P/E versus 41. 4x for TETRA Technologies, Inc. — 33. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 99. 0% to $33. 50.
08Which pays a better dividend — IRBT or NVCR or HELE or SWK or TTI?
In this comparison, SWK (4.
1% yield) pays a dividend. IRBT, NVCR, HELE, TTI do not pay a meaningful dividend and should not be held primarily for income.
09Is IRBT or NVCR or HELE or SWK or TTI better for a retirement portfolio?
For long-horizon retirement investors, Stanley Black & Decker, Inc.
(SWK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4. 1% yield). iRobot Corporation (IRBT) carries a higher beta of 5. 21 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SWK: -1. 5%, IRBT: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IRBT and NVCR and HELE and SWK and TTI?
These companies operate in different sectors (IRBT (Consumer Cyclical) and NVCR (Healthcare) and HELE (Consumer Defensive) and SWK (Industrials) and TTI (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IRBT is a small-cap quality compounder stock; NVCR is a small-cap quality compounder stock; HELE is a small-cap quality compounder stock; SWK is a mid-cap income-oriented stock; TTI is a small-cap quality compounder stock. SWK pays a dividend while IRBT, NVCR, HELE, TTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.